Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer.
about
EBAG9 adds a new layer of control on large dense-core vesicle exocytosis via interaction with SnapinReevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker.Bayesian joint analysis of heterogeneous genomics data.Preclinical evaluation on the tumor suppression efficiency and combination drug effects of fermented wheat germ extract in human ovarian carcinoma cells.The analysis of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) immunoreactivity within the microenvironment of the ovarian cancer lesion relative to the applied therapeutic strategy.Akt3 controls vascular endothelial growth factor secretion and angiogenesis in ovarian cancer cells.Epitomics: serum screening for the early detection of cancer on microarrays using complex panels of tumor antigens.Epigenetics in human melanoma.Cisplatin-, Doxorubicin-, and Docetaxel-Induced Cell Death Promoted by the Aqueous Extract of Solanum nigrum in Human Ovarian Carcinoma Cells.EBAG9 inducing hyporesponsiveness of T cells promotes tumor growth and metastasis in 4T1 murine mammary carcinoma.EBAG9 modulates host immune defense against tumor formation and metastasis by regulating cytotoxic activity of T lymphocytesExtracellular vesicle-mediated EBAG9 transfer from cancer cells to tumor microenvironment promotes immune escape and tumor progression.Estrogen receptor-binding fragment-associated gene 9 expression and its clinical significance in human testicular cancer.
P2860
Q24556574-54CBCB3B-5A4B-42B7-8306-7930A8B6092AQ24814042-C99D8DD3-9201-4D5C-BD3F-525EE411631DQ30747001-91C95AA5-5F32-49C9-BCC7-89809F64D326Q35178056-E1FFB60C-9FBF-450C-AFB3-328AB376B3A0Q35201592-3E5ADDF0-71AE-4121-8768-B8A0B78DC072Q35291703-7C930F51-C01A-45FF-9B09-E209B7AF6FE3Q36252189-34642F70-5566-495E-9BE2-FED2152E83B6Q37531849-2A6708BA-0F87-433C-B67C-FC37F8FBEB8EQ38864663-35C9BFE6-557D-4351-8864-E057D2383EF8Q39850984-F5E17037-21E3-4347-BEB3-1A0BA891DA45Q42536212-4BB8BD23-0AEE-46A9-A1EE-D3E054DBA94FQ49838785-7EBD93AE-5D0D-4C95-A40E-D28F7FEC83FBQ51829383-51476AFB-2A32-4B6F-A60F-473B58E8B110
P2860
Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Expression of EBAG9/RCAS1 is a ...... man epithelial ovarian cancer.
@ast
Expression of EBAG9/RCAS1 is a ...... man epithelial ovarian cancer.
@en
type
label
Expression of EBAG9/RCAS1 is a ...... man epithelial ovarian cancer.
@ast
Expression of EBAG9/RCAS1 is a ...... man epithelial ovarian cancer.
@en
prefLabel
Expression of EBAG9/RCAS1 is a ...... man epithelial ovarian cancer.
@ast
Expression of EBAG9/RCAS1 is a ...... man epithelial ovarian cancer.
@en
P2093
P2860
P356
P1476
Expression of EBAG9/RCAS1 is a ...... man epithelial ovarian cancer.
@en
P2093
J-I Akahira
N Yaegashi
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601832
P407
P577
2004-06-01T00:00:00Z